AVXL
Price
$10.79
Change
+$0.22 (+2.08%)
Updated
Jul 3 closing price
Capitalization
921.16M
37 days until earnings call
EYPT
Price
$9.72
Change
+$0.06 (+0.62%)
Updated
Jul 3 closing price
Capitalization
668.85M
24 days until earnings call
Interact to see
Advertisement

AVXL vs EYPT

Header iconAVXL vs EYPT Comparison
Open Charts AVXL vs EYPTBanner chart's image
Anavex Life Sciences
Price$10.79
Change+$0.22 (+2.08%)
Volume$800.37K
Capitalization921.16M
EyePoint Pharmaceuticals
Price$9.72
Change+$0.06 (+0.62%)
Volume$332.55K
Capitalization668.85M
AVXL vs EYPT Comparison Chart in %
Loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVXL vs. EYPT commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Buy and EYPT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (AVXL: $10.79 vs. EYPT: $9.72)
Brand notoriety: AVXL and EYPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 88% vs. EYPT: 41%
Market capitalization -- AVXL: $921.16M vs. EYPT: $668.85M
AVXL [@Biotechnology] is valued at $921.16M. EYPT’s [@Biotechnology] market capitalization is $668.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileEYPT’s FA Score has 1 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • EYPT’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than AVXL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 6 TA indicator(s) are bullish while EYPT’s TA Score has 4 bullish TA indicator(s).

  • AVXL’s TA Score: 6 bullish, 4 bearish.
  • EYPT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AVXL is a better buy in the short-term than EYPT.

Price Growth

AVXL (@Biotechnology) experienced а +12.75% price change this week, while EYPT (@Biotechnology) price change was -6.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

AVXL is expected to report earnings on Aug 12, 2025.

EYPT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($921M) has a higher market cap than EYPT($669M). EYPT YTD gains are higher at: 30.470 vs. AVXL (0.466). AVXL has higher annual earnings (EBITDA): -45.65M vs. EYPT (-144.55M). EYPT has more cash in the bank: 318M vs. AVXL (116M). AVXL has less debt than EYPT: AVXL (88.2K) vs EYPT (24.1M). EYPT has higher revenues than AVXL: EYPT (56M) vs AVXL (0).
AVXLEYPTAVXL / EYPT
Capitalization921M669M138%
EBITDA-45.65M-144.55M32%
Gain YTD0.46630.4702%
P/E RatioN/AN/A-
Revenue056M-
Total Cash116M318M36%
Total Debt88.2K24.1M0%
FUNDAMENTALS RATINGS
AVXL vs EYPT: Fundamental Ratings
AVXL
EYPT
OUTLOOK RATING
1..100
3374
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
61
Fair valued
PROFIT vs RISK RATING
1..100
7592
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
3737
P/E GROWTH RATING
1..100
10017
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EYPT's Valuation (61) in the Pharmaceuticals Major industry is in the same range as AVXL (62) in the Biotechnology industry. This means that EYPT’s stock grew similarly to AVXL’s over the last 12 months.

AVXL's Profit vs Risk Rating (75) in the Biotechnology industry is in the same range as EYPT (92) in the Pharmaceuticals Major industry. This means that AVXL’s stock grew similarly to EYPT’s over the last 12 months.

AVXL's SMR Rating (97) in the Biotechnology industry is in the same range as EYPT (97) in the Pharmaceuticals Major industry. This means that AVXL’s stock grew similarly to EYPT’s over the last 12 months.

AVXL's Price Growth Rating (37) in the Biotechnology industry is in the same range as EYPT (37) in the Pharmaceuticals Major industry. This means that AVXL’s stock grew similarly to EYPT’s over the last 12 months.

EYPT's P/E Growth Rating (17) in the Pharmaceuticals Major industry is significantly better than the same rating for AVXL (100) in the Biotechnology industry. This means that EYPT’s stock grew significantly faster than AVXL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLEYPT
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
78%
Momentum
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AGSCX6.220.07
+1.14%
Alger Small Cap Growth C
FSTRX34.010.22
+0.65%
Federated Hermes MDT Large Cap Value A
FAAIX29.720.12
+0.41%
Fidelity Advisor Asset Manager 70% I
PZFVX25.550.06
+0.24%
JHancock Classic Value A
JINTX34.240.05
+0.15%
Johnson International

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with PLRX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
+2.08%
PLRX - AVXL
47%
Loosely correlated
+5.00%
TENX - AVXL
45%
Loosely correlated
+1.22%
RXRX - AVXL
44%
Loosely correlated
+1.15%
EYPT - AVXL
41%
Loosely correlated
+0.62%
MNMD - AVXL
39%
Loosely correlated
+1.27%
More

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
+0.62%
OCUL - EYPT
64%
Loosely correlated
+1.69%
LYRA - EYPT
58%
Loosely correlated
-3.33%
RXRX - EYPT
55%
Loosely correlated
+1.15%
BEAM - EYPT
55%
Loosely correlated
+0.65%
CRSP - EYPT
54%
Loosely correlated
+0.97%
More